CARE Ratings Zukünftiges Wachstum

Future Kriterienprüfungen 2/6

CARE Ratings wird ein jährliches Gewinn- und Umsatzwachstum von 15.7% bzw. 13.9% prognostiziert. Der Gewinn pro Aktie wird voraussichtlich wachsen um 15.6% pro Jahr. Die Eigenkapitalrendite wird in 3 Jahren voraussichtlich 19.5% betragen.

Wichtige Informationen

15.7%

Wachstumsrate der Gewinne

15.6%

EPS-Wachstumsrate

Capital Markets Gewinnwachstum	12.8%
Wachstumsrate der Einnahmen	13.9%
Zukünftige Eigenkapitalrendite	19.5%
Analystenabdeckung	Low
Zuletzt aktualisiert	13 May 2024

Jüngste Aktualisierungen zum künftigen Wachstum

Recent updates

CARE Ratings Limited's (NSE:CARERATING) Business Is Yet to Catch Up With Its Share Price

Feb 02

CARE Ratings Limited (NSE:CARERATING) Just Released Its Third-Quarter Earnings: Here's What Analysts Think

Feb 01

CARE Ratings (NSE:CARERATING) Has Announced That It Will Be Increasing Its Dividend To ₹6.00

Aug 21

CARE Ratings (NSE:CARERATING) Is Increasing Its Dividend To ₹6.00

Aug 06

Read This Before Buying CARE Ratings Limited (NSE:CARERATING) For Its Dividend

Apr 01

How Much Did CARE Ratings'(NSE:CARERATING) Shareholders Earn From Share Price Movements Over The Last Three Years?

Mar 05

What Kind Of Shareholders Hold The Majority In CARE Ratings Limited's (NSE:CARERATING) Shares?

Feb 05

Tread With Caution Around CARE Ratings Limited's (NSE:CARERATING) 3.7% Dividend Yield

Jan 01

If You Had Bought CARE Ratings' (NSE:CARERATING) Shares Three Years Ago You Would Be Down 63%

Nov 27

Gewinn- und Umsatzwachstumsprognosen

NSEI:CARERATING - Zukünftige Analystenschätzungen und Finanzdaten der Vergangenheit (INR Millions)
Datum	Umsatz	Gewinne	Freier Cashflow	Bargeld aus operativen Tätigkeiten	Durchschn. Anz. Analysten
3/31/2027	5,065	1,635	1,821	1,384	1
3/31/2026	4,430	1,456	1,563	1,150	1
3/31/2025	3,870	1,251	1,344	958	1
3/31/2024	3,317	1,005	817	909	N/A
12/31/2023	3,190	960	N/A	N/A	N/A
9/30/2023	3,025	885	749	869	N/A
6/30/2023	2,908	877	N/A	N/A	N/A
3/31/2023	2,790	835	707	822	N/A
12/31/2022	2,674	868	N/A	N/A	N/A
9/30/2022	2,614	854	684	871	N/A
6/30/2022	2,530	777	N/A	N/A	N/A
3/31/2022	2,476	751	490	680	N/A
12/31/2021	2,613	783	N/A	N/A	N/A
9/30/2021	2,608	824	537	638	N/A
6/30/2021	2,603	912	N/A	N/A	N/A
3/31/2021	2,484	895	817	862	N/A
12/31/2020	2,348	787	N/A	N/A	N/A
9/30/2020	2,353	775	-723	-686	N/A
6/30/2020	2,311	785	N/A	N/A	N/A
3/31/2020	2,436	824	628	674	N/A
12/31/2019	2,671	1,035	N/A	N/A	N/A
9/30/2019	2,839	1,167	N/A	N/A	N/A
6/30/2019	3,089	1,256	N/A	N/A	N/A
3/31/2019	3,190	1,375	823	1,086	N/A
12/31/2018	3,285	1,431	N/A	N/A	N/A
9/30/2018	3,335	1,500	N/A	N/A	N/A
6/30/2018	3,297	1,526	N/A	N/A	N/A
3/31/2018	3,327	1,624	1,314	1,338	N/A
3/31/2017	2,874	1,476	N/A	1,190	N/A
3/31/2016	2,796	1,196	N/A	1,064	N/A
3/31/2015	2,605	1,378	N/A	1,072	N/A
3/31/2014	2,356	1,294	N/A	1,069	N/A

Analystenprognosen zum zukünftigen Wachstum

Einkommen vs. Sparrate: CARERATINGDas prognostizierte Gewinnwachstum (15.7% pro Jahr) liegt über der Sparquote (6.7%).

Ertrag vs. Markt: CARERATINGDie Erträge des Unternehmens (15.7% pro Jahr) werden voraussichtlich langsamer wachsen als der Markt Indian (16% pro Jahr).

Hohe Wachstumserträge: CARERATINGDie Erträge des Unternehmens werden voraussichtlich steigen, jedoch nicht deutlich.

Einnahmen vs. Markt: CARERATINGDie Einnahmen des Unternehmens (13.9% pro Jahr) werden voraussichtlich schneller wachsen als der Markt Indian (9.6% pro Jahr).

Hohe Wachstumseinnahmen: CARERATINGDie Einnahmen des Unternehmens (13.9% pro Jahr) werden voraussichtlich langsamer wachsen als 20% pro Jahr.

Wachstumsprognosen für den Gewinn je Aktie

Künftige Eigenkapitalrendite

Künftige Eigenkapitalrendite: CARERATINGDie Eigenkapitalrendite des Unternehmens wird in 3 Jahren voraussichtlich niedrig sein (19.5%).

CARE Ratings Zukünftiges Wachstum

Future Kriterienprüfungen 2/6

Wichtige Informationen

Jüngste Aktualisierungen zum künftigen Wachstum

Price target increased by 24% to ₹938

Price target increased by 15% to ₹711

Price target decreased to ₹511

Price target decreased to ₹621

Price target decreased to ₹707

Consensus EPS estimates fall by 11%

Recent updates

CARE Ratings Limited Approves Final Dividend for the Financial Year 2023-24

Full year 2024 earnings: EPS misses analyst expectations

Upcoming dividend of ₹11.00 per share

High number of new directors

CARE Ratings Limited, Annual General Meeting, Jul 09, 2024

Full year 2024 earnings released: EPS: ₹33.77 (vs ₹28.17 in FY 2023)

CARE Ratings Limited Recommends Final Dividend for the Financial Year 2024, Payable on June 21, 2024

CARE Ratings Limited to Report Q4, 2024 Results on May 09, 2024

Price target increased by 24% to ₹938

New major risk - Revenue and earnings growth

CARE Ratings Limited's (NSE:CARERATING) Business Is Yet to Catch Up With Its Share Price

Third quarter 2024 earnings released: EPS: ₹7.88 (vs ₹5.38 in 3Q 2023)

CARE Ratings Limited to Report Q3, 2024 Results on Jan 24, 2024

Upcoming dividend of ₹7.00 per share at 2.0% yield

Second quarter 2024 earnings released: EPS: ₹11.83 (vs ₹11.57 in 2Q 2023)

CARE Ratings Limited Approves Interim Dividend for the Financial Year 2023-24

CARE Ratings Limited to Report Q2, 2024 Results on Oct 31, 2023

Investor sentiment improves as stock rises 17%

Care Ratings Limited Announces Change in Composition of Strategy and Investment Committee

First quarter 2024 earnings released: EPS: ₹6.00 (vs ₹4.61 in 1Q 2023)

CARE Ratings Limited Announces Executive Changes

CARE Ratings Limited Approves Special Dividend for the Financial Year 2022-23

CARE Ratings Limited Announces Changes in Roles of Senior Management Personnel

Care Ratings Limited Proposes special Dividend for the Financial Year 2022-23

Upcoming dividend of ₹15.00 per share at 2.4% yield

Full year 2023 earnings released: EPS: ₹28.17 (vs ₹25.45 in FY 2022)

CARE Ratings Limited, Annual General Meeting, Jul 28, 2023

Price target increased by 15% to ₹711

CARE Ratings Limited Announces The Hon'ble Madras High Court Passes Orders on February 1, 2023, in Batch of Interim Applications Filed by 63 Moons Technologies Ltd

Upcoming dividend of ₹10.00 per share at 2.8% yield

Third quarter 2023 earnings released: EPS: ₹5.38 (vs ₹4.93 in 3Q 2022)

CARE Ratings Limited Announces Board Changes

CARE Ratings Limited to Report Q3, 2023 Results on Jan 28, 2023

CARE Ratings Limited Announces Resignation of Shubhangi Soman as Non-Executive Non-Independent Director

CARE Ratings Limited Approves Appointment of Gurumoorthy Mahalingam as Additional Director, Effective November 21, 2022

Price target decreased to ₹511

Second quarter 2023 earnings released: EPS: ₹11.57 (vs ₹9.03 in 2Q 2022)

CARE Ratings Limited to Report Q2, 2023 Results on Nov 08, 2022

CARE Ratings Limited Announces Reconstitution of Rating Sub-Committee

Care Ratings Limited Confirms Interim and Final Dividend for the Financial Year 2021-22

Care Ratings Limited Announces Resignation of Ananth Narayan Gopalakrishnan as Non-Executive Independent Director of the Company

Upcoming dividend of ₹10.00 per share

Care Ratings Limited Announces Resignation of Ananth Narayan Gopalakrishnan as Non-Executive Independent Director of the Company

High number of new directors

First quarter 2023 earnings released: EPS: ₹4.61 (vs ₹3.75 in 1Q 2022)

CARE Ratings Limited, Annual General Meeting, Sep 26, 2022

CARE Ratings Limited to Report Q1, 2023 Results on Jul 29, 2022

CARE Ratings Limited (NSEI:CARERATING) announces an Equity Buyback for 2,368,000 shares, representing 7.99% for INR 1,219.52 million.

High number of new directors

Price target decreased to ₹621

Care Ratings Limited Recommends Final Dividend for the Financial Year 2021 22

Full year 2022 earnings: EPS and revenues miss analyst expectations

CARE Ratings Limited to Report Q4, 2022 Results on May 28, 2022

Investor sentiment deteriorated over the past week

Care Ratings Limited Announces Resignation of Ajay Mahajan as the Managing Director

High number of new directors

Price target decreased to ₹707

Consensus EPS estimates fall by 11%

CARE Ratings Limited (NSE:CARERATING) Just Released Its Third-Quarter Earnings: Here's What Analysts Think

Price target decreased to ₹734

Third quarter 2022 earnings: EPS exceeds analyst expectations while revenues lag behind

CARE Ratings Limited Appoints Shubhangi Soman as an Additional Director

High number of new directors

Upcoming dividend of ₹6.00 per share

CARE Ratings (NSE:CARERATING) Has Announced That It Will Be Increasing Its Dividend To ₹6.00

CARE Ratings (NSE:CARERATING) Is Increasing Its Dividend To ₹6.00

First quarter 2022 earnings released: EPS ₹3.75 (vs ₹3.17 in 1Q 2021)

Consensus EPS estimates increase to ₹32.20

Investor sentiment improved over the past week